These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 8347771)
1. Effect of syngeneic islet antigen administration on complement-dependent antibody-mediated cytotoxicity to islet cells and diabetes onset in diabetes-prone BB/OK rats. Schröder D; Schmidt S; Klöting I; Hehmke B Autoimmunity; 1993; 14(4):283-9. PubMed ID: 8347771 [TBL] [Abstract][Full Text] [Related]
2. Early appearance of complement-dependent antibody mediated cytotoxicity (C'AMC) to islet cells in serum of diabetes-prone BB/OK rats. Hehmke B; Schröder D; Klöting I Diabetes Res; 1990 Apr; 13(4):183-6. PubMed ID: 2134210 [TBL] [Abstract][Full Text] [Related]
3. Complement-dependent antibody-mediated cytotoxicity in the spontaneously diabetic BB/OK rat: association with beta cell volume density. Hehmke B; Lucke S; Schröder D; Klöting I; Kohnert KD Eur J Immunol; 1990 May; 20(5):1091-6. PubMed ID: 2192902 [TBL] [Abstract][Full Text] [Related]
4. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity. Schröder D; Wanka H; Hehmke B; Klöting I; Köhler E; Knospe S; Schmidt S Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197 [TBL] [Abstract][Full Text] [Related]
5. Complement-dependent antibody-mediated cytotoxicity (C'AMC) to pancreatic islet cells in the spontaneously diabetic BB/OK rat: interference from cell-bound and soluble inhibitors. Hehmke B; Schröder D; Klöting I; Kohnert KD J Clin Lab Immunol; 1991 Jun; 35(2):71-81. PubMed ID: 1668761 [TBL] [Abstract][Full Text] [Related]
6. Detection and time course of humoral-mediated cytotoxicity to different cell types in diabetes-prone BB/OK rats. Schröder D; Hehmke B; Klöting I; Schmidt S Diabetes Res; 1991 Jun; 17(2):81-91. PubMed ID: 1817815 [TBL] [Abstract][Full Text] [Related]
7. In vitro stimulation by islet antigen facilitates the detectability of beta-cell reactive cells in diabetes-prone BB/OK rats. Wanka H; Kuttler B; Knospe S; Hahn HJ Autoimmunity; 1999; 30(4):223-34. PubMed ID: 10524498 [TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immune reactions against islets of Langerhans in diabetes-prone BB rats. Knospe S; Köhler E; Klöting I Exp Clin Endocrinol; 1987 Aug; 89(3):290-6. PubMed ID: 3311775 [TBL] [Abstract][Full Text] [Related]
9. Humoral-mediated anti-islet cytotoxicity in diabetes-prone BB/OK rats--effect on beta-cell function and autologous islets. Schröder D; Hehmke B; Klöting I; Besch W; Schmidt S Exp Clin Endocrinol; 1990 Feb; 95(1):22-30. PubMed ID: 2185938 [TBL] [Abstract][Full Text] [Related]
10. Prevention and suppression of autoimmune pancreatic beta-cell destruction in BB rats by syngeneic lymphocytes obtained from long-term normoglycaemic donors. Kuttler B; Dunger A; Volk HD; Diamantstein T; Hahn HJ Diabetologia; 1991 Feb; 34(2):74-7. PubMed ID: 2065851 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic insulin treatment of diabetes-prone BB/OK rats by application of a sustained release insulin implant. Schröder D; Ratke M; Bauer UC; Klöting I; Ziegler B; Schmidt S Autoimmunity; 2002 Mar; 35(2):143-53. PubMed ID: 12071437 [TBL] [Abstract][Full Text] [Related]
12. Humoral-mediated cytotoxicity to rat pancreatic exocrine cells in serum of diabetes-prone BB/OK rats--predictive value for diabetes onset. Schröder D; Hehmke B; Klöting I; Schmidt S Diabetes Res; 1993; 23(3):105-13. PubMed ID: 7712684 [TBL] [Abstract][Full Text] [Related]
13. Occurrence of islet cell reactive autoantibodies in diabetes-prone BB/OK rats is not associated with the onset of diabetes: a cross-sectional study of BB rats and their diabetes-resistant congenic strains. Schlosser M; Ziegler B; Augstein P; Klöting I; Ziegler M Diabetes Res; 1994; 26(2):67-77. PubMed ID: 7554727 [TBL] [Abstract][Full Text] [Related]
14. Syngeneic islet transplantation in prediabetic BB-DP rats--a synchronized model for studying beta-cell destruction during the development of IDDM. Christensen UB; Sparre T; Cooke A; Andersen HU; Mandrup-Poulsen T; Nerup J Autoimmunity; 1998; 28(2):91-107. PubMed ID: 9771979 [TBL] [Abstract][Full Text] [Related]
15. Effect of serum from diabetes-prone BB/OK rats on neonatal rat pancreatic islets and islet cell suspensions. Schröder D; Hehmke B; Klöting I; Besch W Exp Clin Endocrinol; 1989 May; 93(2-3):187-92. PubMed ID: 2673813 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies. Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475 [TBL] [Abstract][Full Text] [Related]
18. Spontaneously diabetic BB rats have age-dependent islet beta-cell-specific surface antibodies at clinical onset. Pipeleers D; Van de Winkel M; Dyrberg T; Lernmark A Diabetes; 1987 Oct; 36(10):1111-5. PubMed ID: 3308581 [TBL] [Abstract][Full Text] [Related]
19. Immune islet killing mechanisms associated with insulin-dependent diabetes: three rabbit antibody-mediated islet cell cytotoxicity models. Charles MA; Suzuki M; Slater L; Waldeck N; Ong K Diabetologia; 1983 Oct; 25(4):348-54. PubMed ID: 6357917 [TBL] [Abstract][Full Text] [Related]
20. Identification of T cell subsets and class I and class II antigen expression in islet grafts and pancreatic islets of diabetic BioBreeding/Worcester rats. Weringer EJ; Like AA Am J Pathol; 1988 Aug; 132(2):292-303. PubMed ID: 3135758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]